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Background: Higher levels of early maladaptive schemas (EMS) and schema modes according to schematherapy
by Jeffrey Young are present in obsessive-compulsive disorder (OCD) compared to healthy controls. This study
examines the relationship of EMS and schema modes to OC symptom severity and the predictive value of EMS and
schema modes on treatment outcome in inpatients receiving Cognitive-Behavioral Therapy (CBT) with Exposure
and Response Prevention (ERP). The main assumption was a negative association between the EMS of the domain
‘disconnection’ and dysfunctional coping and parent schema modes and the treatment outcome.
Methods: EMS, schema modes, depression and traumatic childhood experiences were measured in 70 patients
with OCD. To analyze the predictors, two regression analyses were conducted considering multiple variables, such
as depression, as covariates.
Results: Regression analyses demonstrated that higher scores on the EMS named failure and emotional inhibition
and depressive symptom severity at pretreatment were significantly related to poor outcome and explained a high
percentage of the variance in OC symptoms at posttreatment. No influence on the treatment outcome was
observed for schema modes, other EMS or other covariates.
Conclusions: The results support the approach to extend the CBT with ERP treatment with therapeutic elements
focusing on maladaptive schemas, particularly in non-responders.Background
Obsessive-compulsive disorder (OCD) is among the
most common mental disorders, showing a lifetime
prevalence of 2-3% [1]. It is characterized by intrusive
thoughts, images or impulses (obsessions) and ritualized
repetitive behaviors (compulsions) that cause significant
dysfunction and distress. If no adequate treatment is ad-
ministered, OCD typically takes a chronic course [2].
Cognitive-Behavioral Therapy (CBT) with Exposure and
Response Prevention (ERP) is the first-line treatment for
OCD according to standard guidelines [2-7]. Meta-analyses
confirm that the main components of CBT, cognitive and
behavioral interventions such as ERP are comparable in* Correspondence: nicola.thiel@uniklinik-freiburg.de
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unless otherwise stated.their efficacy [8-11]. More specifically, in meta-analyses,
CBT with ERP displays large between group effect sizes of
d = 1.3 to 1.5 in comparison with control groups and cog-
nitive restructuring reveals effect sizes of d = 1.1 to 1.5
[2,10-12]. However, it should be taken into account that a
strict separation of cognitive interventions in ERP treat-
ment is difficult because cognitive techniques are associ-
ated with ERP in some way in most studies [2].
Over the past years, cognitive interventions that have
been effective in the treatment of depression and anxiety
disorders were adapted to a CBT model addressing typ-
ical dysfunctional assumptions in OCD, such as inflated
responsibility, perfectionism, overestimation of threat
and intolerance of uncertainty [13-18]. However, only a
few studies have addressed the origin of these beliefs.
Aaron Beck [19] assumed that negative and stressful ex-
periences during childhood may lead to the consolida-
tion of maladaptive core beliefs in individuals, so-calledhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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These schemas are assumed to be stable patterns of
dysfunctional cognitive processing that may become
reactivated by stressful situations [20]. To our know-
ledge, in OCD, there is only one cognitive treatment
approach focusing on schemas, demonstrating a long
lasting constellation of inveterate dysfunctional core be-
liefs in treatment-resistant OCD patients [21]. This inte-
grative schema treatment approach showed clinically
significant improvement for 32 patients who were resist-
ant to standard CBT and revealed that maladaptive sche-
mas improved for responders and did not change for
non-responders [21].
According to the schema therapy developed by Young
[22], schemas named early maladaptive schemas (EMS)
are defined as self-perpetuating dysfunctional cognitive
patterns that emerge from unmet basic needs and trau-
matic experiences during childhood [23]. EMS consist of
memories, emotions, cognitions and physical sensations
that influence thinking and behavior in a dysfunctional
way and are stable over time, even after evidence-based
treatment of depressed patients [23,24]. Young as-
sumes 18 EMS and groups them into five domains:
Disconnection, Impaired Autonomy, Impaired Limits,
Other-Directedness and Overvigilance & Inhibition. For
a detailed description of the 18 EMS and the domains,
please refer to Young and colleagues [23].
Despite the effectiveness of CBT with ERP, studies
demonstrate that 17 - 33% of OCD patients do not suffi-
ciently respond to ERP, and 5-29% drop out or refuse
treatment [17,25-28]. An increased knowledge about
underlying EMS among patients with OCD, particularly
among non-responders, is important to gain a deeper
understanding of the relationship between core beliefs
and treatment outcome and could indicate how to im-
prove the treatment. Some literature has demonstrated
the role of EMS in depression, anxiety and eating disor-
ders [24,29,30]. Specifically, increased values in the first
EMS domain, Disconnection, representing ones ex-
pectation that the basic need for security, safety and
empathy by others will not be met, are often associ-
ated with particularly strong symptomatic impairment,
and studies demonstrate a relation to depressive symptom
severity [23,24].
Studies relating EMS to OCD are relatively sparse.
Three studies examined EMS at a descriptive level
[31-33]. In the first study, significantly higher scores in
five of 15 EMS were found in OCD in comparison
with trichotillomania (so-called mistrust, social isola-
tion, shame, subjugation and emotional inhibition)
[32]. Atalay et al. [31] demonstrated that the EMS
questionnaire total score, as well as the schemas social
isolation, vulnerability and pessimism, were significantly
increased in OCD in relation to healthy controls.Voderholzer et al. [33] examined 18 EMS in OCD com-
pared to eating disorder, chronic pain disorder and
healthy controls. The patient group could be signifi-
cantly differentiated from the healthy controls in 17 of
the EMS. In addition, OCD patients scored higher on
four EMS (abandonment, dependence, vulnerability and
insufficient self-control) than the eating and chronic
pain disorders. In summary, higher levels of EMS in
clinical samples compared to healthy controls were
proven in all studies. Thus, there is preliminary evidence
about the schema construct that inspired us to investigate
the predictive value of EMS in treatment outcome. Cur-
rently available data are insufficiently stringent to make an
accurate prediction. Only one study investigated EMS pre-
dictors in 88 OCD patients completing ERP treatment
[34]. The EMS named abandonment was identified as a
negative predictor and the EMS self-sacrifice was related
to a positive treatment outcome. This interesting study
had the limitation that only pretreatment OCD severity
and depression were considered as moderating factors in
the regression analysis. Other proven predictors in OCD
such as hoarding, number of comorbid Axis I disorders,
age at onset or gender, which are described as predictors
for treatment response in the OCD literature, were not in-
cluded [56-60]. Moreover, the importance of traumatic life
events for the development of OCD is discussed increas-
ingly in the literature [35-40]. Even though findings on the
relationship between traumatisation and OCD are still
humble, there are results showing higher levels of ‘minor
traumatisations’ such as emotional and physical neglect or
emotional abuse in OCD [41] Since these traumas have an
important part in the development of EMS, the predictive
value of traumatisation should be included in the statis-
tical analyses. At this stage, results on the predictive value
of traumatisation in OCD are heterogeneous [39,42]. Be-
cause these predictors are relevant, our study is of great
importance in the replicability of the results of Haaland
et al. [34] and the extension of the study design.
Since different EMS can be activated at the same time,
and because the same patient can show distinct behav-
iors in specific situations, Young developed so-called
schema modes [22]. Schema modes are assumed to be
predominant emotional states and coping responses that
occur when EMS are triggered. They are assumed to
consist of the current emotional and behavioral state of
an individual, which can change rapidly and can be func-
tional or dysfunctional [35]. To date, approximately 22
schema modes have been identified and were grouped
into four categories: so-called Child modes, Dysfunc-
tional Coping modes, Dysfunctional Parent modes and
the Healthy Adult mode [23,44]. Currently, the schema
mode concept in Axis I disorders is only rarely exam-
ined. Since schema modes can be active during psycho-
therapeutic sessions, influence the session structure in a
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schematherapeutic work more and more on schema
modes than on EMS, it was of great interest to include
schema modes in the analysis of this study [43]. Only
Voderholzer et al. [33] examined these coping responses
called schema modes for the first time in OCD and
proved that OCD patients scored significantly higher
than healthy controls in 10 out of 13 schema modes and
higher than the eating and chronic pain disorder group
in four schema modes (so-called vulnerable child, angry
child, punishing parent and demanding parent).
Problematic axis I behaviour such as pathological drink-
ing or gambling, binge eating or obsessive-compulsive
behaviour is assigned to the Dysfunctional Coping modes
according to the schema theory. They are defined by an
overuse of unhealthy coping styles or defense mecha-
nisms, such as avoidance or overcompensation to be
distracted by negative emotions [43]. Increased distinct
psychopathology and being strongly caught up in the
problem behaviour, as it is often the case in OCD patients,
implies that the corresponding schema mode is stronger
pronounced. Since obsessive-compulsive symptom sever-
ity is a negative predictor for treatment outcome and
patients with increased levels of these modes, typically
show avoiding behaviour such as forgetting sessions or
homework, talking about superficialities or discontinue
the therapy, we assume that pronounced Dysfunctional
Coping modes predict treatment failure. Being in a Dys-
functional Parent mode, patients put extremely high pres-
sure upon themselves or experience self-devaluation
and self-hatred. Unhealthy behaviours and destructive
rules determine the behavior, something that can be ob-
served in OCD patients as well. Patients in these condi-
tions are often difficult to reach, address problems that
they do not work out and frequently reject cooperation
in treatment leading to early dropouts in therapy [43].
Based on this definition of Dysfunctional Parent modes,
we expect a negative correlation with treatment out-
come. In general, it was of great interest to examine, for
the first time, the predictive value of schema modes
in OCD.
In the present study, we sought to further examine the
relationship between EMS and schema modes with OC
symptom severity at baseline as well as the predictive
value of EMS and schema modes on the treatment out-
come in inpatients with OCD receiving CBT with ERP.
Three hypotheses will be examined. First, we assume
that the degree of EMS and schema modes show a posi-
tive relationship with the OCD symptom severity at
baseline. Second, we hypothesized that treatment non-
responders present higher levels of EMS and schema
modes at baseline than responders, and third, we ex-
pected that the EMS of the first domain, related to basic
safety and high levels of the Dysfunctional Coping andParent modes, are negatively related to the treatment
outcome.Methods
Participants
Eighty-four inpatients diagnosed with OCD were recruited
from the Department of Psychiatry and Psychotherapy,
University Medical Center in Freiburg and the Schoen
Clinic Roseneck in Prien. The inclusion criteria were ages
between 18 and 65 years and a primary diagnosis of OCD
as assessed by the Structured Clinical Interview for DSM-
IV (SCID-I) [45]. The SCID-I was administered by trained
and experienced raters. All raters attended a SCID-I and –
II training consisting of a two-day theoretical training and
scoring videos by a certified trainer for SCID. The inpa-
tients were excluded if they had a primary diagnosis
other than OCD, a current or lifetime history of psy-
chotic episodes, substantial neurological impairment,
severe cognitive dysfunction, acute suicidal symptoms
and insufficient German language skills. Four patients
refused to participate in the investigation, four were ex-
cluded due to other primary diagnoses, two due to cog-
nitive dysfunction, two because of comorbid psychotic
episodes and two could not fill out the questionnaires
because of compulsive behavior. Thus, 70 inpatients ful-
filled the inclusion criteria and were included in the
present study. Three patients dropped out during treat-
ment at their own request and did not participate in the
posttreatment evaluation. A detailed description of the
demographic and clinical characteristics is presented in
Table 1.
At pretreatment, the sample was characterized by
moderate to severe levels of obsessive-compulsive symp-
tom severity (M = 23.97, SD = 5.28) according to the Yale-
Brown Obsessive-Compulsive Scale (Y-BOCS) [46]. The
mean duration of the OCD in years was 15.1 (SD = 11.3).
The study was approved by the local Ethics Committee
for research with human subjects. Written informed con-
sent was obtained from all participants prior to baseline
assessment after the rationale of the study was fully ex-
plained to the subjects.Measures
Y-BOCS
The Y-BOCS [46] is a semi-structured, clinically-
administered interview that is considered the gold
standard to assess OCD symptom severity [47,48]. It
has demonstrated a high inter-rater reliability, internal
consistency and convergent validity [46,49]. The first 10
items were used as primary outcomes and are suitable
to demonstrate symptom changes over the course of
treatment [50]. Internal consistency for baseline scores
for the current sample was α = 0.89.
Table 1 Demographic and clinical characteristics of the
sample (N = 70)
Demographics M (SD)
Age in years 35.3 (11.1)





Married or partnered 13 (19)




Disability pension 9 (12)
Unemployed 8 (11)
Clinicals N (%)
At least one comorbid Axis I diagnosis 53 (75.7)
Major depressive disorder 29 (41.2)
Agoraphobic or panic disoder 11 (15.7)
Social- or specific phobia 6 (8.6)
Generalized anxiety disorder 3 (4.3)
PTSD 3 (4.3)
Eating disorder 4 (5.7)
Somatoform disorder 1 (1.4)
M (SD)




Y-BOCSd post-treatment 14.55 (7.02)
Note: aOCI-r: Obsessive Compulsive Inventory-revised, bBDI: Beck Depression
Inventory, cCTQ: Childhood Trauma Questionnaire, dY-BOCS: Yale-Brown
Obsessive-Compulsive Scale.
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The YSQ-S3 [51] is a 90-item self-report instrument that
investigates the presence of 18 EMS with five items per
scale. Each item is a statement of a character issue that
the patient scores on a 6-step Likert-type response format
ranging from completely untrue for me to describes me
perfectly. Higher scores indicate a stronger presence of the
respective schema. Adequate reliability, convergent, fac-
torial and discriminant validity have been demonstrated
for the German version [52]. In the current sample,
Cronbach’s alpha for the baseline YSQ-total was α = 0.96.
Schema Mode Inventory (SMI-r)
The SMI-r [53] is a 124-item self-report questionnaire
that investigates the presence of 14 schema modes with4 to 10 items in each subscale. Each item is rated on a
6-step Likert-type scale. Higher scores indicate a stron-
ger presence of the schema mode. The so-called perfec-
tionistic and the suspicious overcontroller mode were
added as explorative scales because the manifestation of
the perfectionistic overcontroller mode seemed particu-
larly interesting in patients with OCD. For a brief de-
scription of the schema modes, see Young, Klosko and
Weishaar [23]. The German version demonstrated good-
to-excellent internal consistency and construct validity.
Furthermore, the 14-factor structure was approved [54].
Internal consistency for baseline scores for the current
sample was α = 0.91.
Beck Depression Inventory-II (BDI-II)
The BDI-II [55] is a well-known 21 item self-report
measure of the severity of depressive symptoms. It has
demonstrated high internal consistency, test-retest reli-
ability and construct validity that also applies to the
German version [56]. In the current sample, Cronbach’s
alpha for the BDI at baseline was α = 0.93.
Obsessive Compulsive Inventory-revised (OCI-r)
The OCI-R [57] is a self-report measure for assessing
symptoms of OCD. It contains 18 Items and six sub-
scales and has good psychometric properties [57-59].
These apply likewise for the German version [60]. In the
current sample, Cronbach’s alpha for the OCI-r total
score at baseline was α = 0.82.
Childhood Trauma Questionnaire (CTQ)
The CTQ [61] is a 31-item self-report instrument that
retrospectively assesses the subjective frequency of five
forms of childhood trauma experienced with good psy-
chometric properties. The CTQ measures five domains:
emotional abuse, physical abuse, sexual abuse, emotional
neglect and physical neglect. For the German version,
the factor structure, good reliability and validity were
demonstrated [62]. In the current sample, Cronbach’s
alpha for the CTQ total score at baseline was α = 0.67.
Life satisfaction
Life satisfaction was assessed by a self-rating ranging from
‘very dissatisfied’ (1) to ‘very satisfied’ with my life’ (10).
Procedure
Every patient admitted to one of the two hospitals for an
OCD treatment was informed about the study. If the pa-
tient agreed to participate, the Axis I disorders diagnoses
were confirmed by the SCID-I within the first seven days
of treatment. If the inpatient met the inclusion criteria,
the severity of the OC symptoms was assessed based on
the Y-BOCS, and the questionnaires (see 2.2) were handed
out. All patients participated in a multimodal inpatient
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treatment manual by Lakatos and Reinecker [63]. The
treatment consisted of twice-weekly individual therapy
sessions (50 min each) and a weekly educational group
(90 min) conducted by experienced therapists having
weekly team meetings to discuss ongoing cases and
difficulties. After the general education regarding OCD
and the development of an individual disease model, a
fear hierarchy was constructed. The exposure began
with moderately anxiety-provoking situations and in-
creased to the most distressing fear and was conducted
therapist-accompanied within the therapy sessions as
well as in homework assignments. The ERP was com-
bined with the identification of negative beliefs and
appraisals as well as cognitive restructuring. A total of
46 inpatients (65,7%) received selective serotonin-reuptake
inhibitors (SSRI) or selective serotonin-noradrenalin re-
uptake inhibitors (SNRI). The mean duration of the
inpatient stay in the current sample was 10.6 weeks
(SD = 4.4), 21 individual therapy sessions. OC symptom
severity was again evaluated posttreatment.
Data analysis
To test the first hypothesis, correlation analyses were
conducted to investigate the relationship between EMS,
schema modes and obsessive-compulsive symptoms at
pretreatment. To verify the second hypothesis, in a first
step, responders were defined as those subjects who
showed clinically significant change (CSC) after treat-
ment according to the two-fold criterion provided by
Jacobson and Truax [64]. CSC is fulfilled if (a) a symp-
tom score is under a calculated cut-off score at post-
treatment and (b) a symptom score had decreased by a
reliable amount of change exceeding the measurement
error (reliable change index (RCI)). The RCI was calcu-
lated based on the test-retest reliability of the Y-BOCS
(r = 0.61) according to Woody et al. [49]. The calculated
cut-off score in the present study to determine the non-
clinical range was Y-BOCS = 13 or below [64]. To
achieve CSC and therefore be classified as a responder, a
patient’s individual change score had to be above 1.96
and the post Y-BOCS score had to be 13 or less. In a
second step, an exploratory one factorial multivariate
analysis of variance (MANOVA) was computed investi-
gating the distribution of the EMS, schema modes and
other variables in the responder- and non-responder
groups. The third hypothesis concerning the identifica-
tion of EMS and schema modes as predictors of treat-
ment outcome was tested based on two regression
analyses. Stepwise multivariate regression analyses were
conducted to test whether EMS and schema modes
predicted treatment outcome using the posttreatment
Y-BOCS as the dependent variable. Because increased
depression rates affect the completion of self-ratingquestionnaires, depressive symptom severity (BDI-II)
was included as a covariate. Furthermore, in all statis-
tical calculations, we controlled for several covariates.
Since baseline obsessive-compulsive symptom severity
(Y-BOCS), number of comorbid Axis I disorders (SCID-I),
age at onset (first onset of symptom measured by self-
rating and alignment with data from previous clinical
reports), gender and hoarding subtype (OCI-r) are con-
sistent described as negative predictors for treatment
response in the OCD literature, they were taken into
account [65-69].
Traumatisation (CTQ) is considered due to the pos-
sible relevance of the development of EMS. Although
specific personality disorders (Cluster A, schizotypal,
narcissistic, two or more comorbid personality disorders)
are associated with poor treatment outcome in patients
with OCD, these predictors were not included in the
analyses because too few patients presented these spe-
cific personality disorders [70].
The statistical assumptions for the regression analyses
were verified with residual plots and histograms for re-
siduals, which showed a normal distribution of the resid-
uals. Prior to the regression analyses, multicollinearity
among the predictor variables was statistically investi-
gated by computing Variance inflation factors (VIF). As
a general rule, a VIF above the cut-off value of 10 indi-
cates a collinearity problem [71]. The VIF was above 1.8
in none of the predictor indicating no significant multi-
collinearity problem. In all analyses, the level of sig-
nificance was set at p ≤ 0.01 (two-tailed tests). The
Statistical Package for Social Sciences (SPSS), version 18,
was used for all calculations. Inter-rater reliability for
the Y-BOCS was determined for a subset of 5 patients
with two raters from Freiburg sitting in the same room,
with no communication between the two during the
interview. The inter-rater reliability between the two
raters was high with intraclass correlation coefficients
(ICCs) of >0.86.
Results
Hypothesis 1: Positive correlations of EMS and schema
modes with the OC symptom severity at baseline
As expected, significant positive correlations of the EMS
and schema modes with the Y-BOCS prior to treatment
(Total score: YSQ ρ = 0.26; p = 0.014 and SMI r = 0.25,
p = 0.018), as well as a highly positive correlation with
the OCI-r pre (Total score: YSQ ρ = 0.45; p < 0.001 and
SMI r = 0.44, p < 0.001), were proven.
Hypothesis 2: Higher levels of EMS and schema modes in
the non-responder than in the responder group
Analyses with paired sample t-tests showed a significant
reduction of obsessive-compulsive symptoms (T = 10,006;
df = 67; p < 0.001) in the Y-BOCS from pre- (M = 24,
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mean Y-BOCS reduction was 37,5%, indicating a positive
outcome of the ERP and pharmacotherapy treatment, as a
symptom reduction of 35% in the literature is designated
as treatment response [3]. According to the 35% symp-
tom reduction criterion, 53% of the patients (N = 37)
achieved treatment response, and 43% (N = 30) were
non-responders. According to the criteria of clinically
significant change (CSC), response was achieved in 27 of
the 67 patients who completed the treatment (38,6% re-
sponders; 57,1% non-responders).
In an exploratory one factorial MANOVA, the distri-
butions of the EMS, schema modes and other variables
in the responder- and non-responder groups were inves-
tigated (see Table 2). The MANOVA yielded a significant
main effect in the YBOCS post between responders and
non-responders (F = 76.6; p < 0.001) and not in the
YBOCS pre. Moreover, non-responders had significantly
higher pretreatment scores on four EMS (emotional
inhibition, social isolation, mistrust/ abuse and defective-
ness) and 4 schema mode variables (vulnerable child,
detached protector, bully and attack and schema mode
global score). In the schema mode named happy child,
non-responders showed significantly lower scores at
pretreatment than responders. For all other EMS and
schema modes, the differences were not significant.
Concerning psychopathological scores, non-responders
showed a significantly lower score in depression symptom
severity and lower scores in life satisfaction at posttreat-
ment. For complete results, see Table 2.
Hypothesis 3: Predictive value of pretreatment EMS and
schema modes on treatment outcome
In a first step, two separate stepwise multivariate re-
gression analyses were computed to reduce the large
number of predictors [72]. First, the 18 EMS and sec-
ond, the 16 schema modes were entered as predic-
tors, while the posttreatment Y-BOCS acted as the
dependent variable. Variables with a significance level
below p < 0.1 were included in further analyses. Con-
cerning the EMS variables, this was obtained for the
EMS constructs of emotional inhibition, failure and
emotional deprivation. For the schema modes, the vulner-
able child and perfectionistic overcompensator met these
criteria.
In a second step, two stepwise multivariate regression
analyses were calculated including the set of covariates
described in 2.4. The aim was to identify the independ-
ent involvement of each variable in the prediction of the
treatment outcome. The first regression explored the
impact of the three EMS and the controlling vari-
ables. The EMS failure explained 21% of the variance
of the treatment outcome, while emotional inhibition
explained an additional 6%. The set of covariates andthe EMS emotional deprivation did not make a significant
contribution.
In the second regression, the predictive value of two
schema modes and the covariates on the treatment out-
come was computed. Depressive symptom severity was
the only variable approved in the analysis, explaining
20% of the variance. The remaining variables were exclu-
ded as predictors. A summary of the regression analyses
is provided in Table 3.
Discussion
The present findings on the EMS and schema mode
construct in OCD extend previous research. Consistent
with our first hypothesis, we demonstrated significant
positive correlations between the degree of EMS and
schema modes with the severity of obsessive-compulsive
symptoms. The second hypothesis received mixed
support. Statistically higher levels of EMS in the non-
responder group could only be detected in four out
of 18 EMS, but responders and non-responders did
not differ in the EMS total score. Concerning schema
modes, non-responders presented significantly higher
scores in 4 out of 15 variables and on the schema
mode global score compared to responders. The third
hypothesis concerning the predictive value of EMS of
the first domain and the Dysfunctional Coping and
Parent modes could not be confirmed. Although non-
responders showed significantly stronger presence of
three out of five EMS in first domain, these EMS
could not be identified as treatment predictors. How-
ever, findings demonstrated that higher scores on the
EMS failure, of the second domain, and emotional inhib-
ition, of the fifth domain, were related to poorer outcomes
in ERP treatment for OCD. Concerning the calculations
regarding the schema modes, only depressive symptom
severity was identified as a negative predictor.
In the following, the identified predictors will be dis-
cussed in detail. Young and colleagues [23] theorized
that the EMS failure involves the perception that one
will inevitably fail or is less successful than others. More-
over, persons who score high on this schema often assume
that they are inept or untalented. Understandably persons
with these assumptions about themselves interfere with
their own efforts in therapy and thus negatively influence
the treatment outcome. The expectation of slight success
becomes a self-fulfilling prophecy, as discussed in the con-
cept of perceived self-efficacy [73]. A considerable number
of studies demonstrated the role of higher treatment
expectations in improved outcomes [74-76], whereas low
expectations were associated with poor treatment out-
comes in CBT of anxiety and depressive disorders [77-79].
Clinicians working with patients presenting a high failure
EMS should articulate the typical assumptions which are
accompanied with this EMS to prevent the reconfirming
Table 2 Comparison of psychopathology scores, early maladaptive schemas and schema modes between responders
and non-responders
M± SD responders M ± SD non-responders F-value p-value
Y-BOCSa (pre) 24.6 ± 6.2 23.6 ± 6.3 0.44 .509
OCI-Rb (pre) 30.1 ± 12.6 30.1 ± 12.6 0.00 .983
BDIc (pre) 16.5 ± 10.7 23.5 ± 13.3 5.18 .026*
CTQd (pre) 43.0 ± 15.5 50.4 ± 20.0 2.63 .110
life satisfaction (pre) 4.2 ± 1.9 3.9 ± 2.2 0.33 .568
life satisfaction (post) 7.0 ± 1.7 4.9 ± 1.8 23.86 <.001***
age of onset 22.1 ± 9.3 18.5 ± 10.2 2.09 .154
treatment duration 14.0 ± 10.8 11.1 ± 3.2 2.57 .114
EMS (Domain, YSQe scales)
Dg: Emotional deprivation 2.5 ± 1.4 2.7 ± 1.4 0.23 .637
Dg: Abandonment 4.0 ± 1.2 3.7 ± 1.2 0.85 .359
Dg: Mistrust/abuse 2.5 ± 0.9 3.2 ± 1.2 6.75 .012*
Dg: Social isolation 2.7 ± 1.3 3.7 ± 1.6 7.44 .008**
Dg: Defectiveness 2.5 ± 1.2 3.2 ± 1.4 4.23 .044*
IAh: Failure 2.7 ± 1.2 3.3 ± 1.4 3.53 .065
IAh: Dependence 3.0 ± 1.0 3.0 ± 1.2 0.00 .986
IAh: Vulnerability 2.6 ± 1.1 3.0 ± 1.0 1.94 .169
IAh: Enmeshment 3.1 ± 1.4 2.8 ± 1.1 0.65 .424
ILi: Entitlement 2.5 ± 0.7 2.8 ± 1.0 1.17 .284
ILi: Insufficient self-control 3.1 ± 0.9 3.4 ± 0.9 2.723 .104
ODj: Subjugation 3.3 ± 1.2 3.6 ± 1.6 1.45 .232
ODj: Self-sacrifice 3.5 ± 1.2 3.4 ± 1.0 0.05 .826
ODj: Approval-seeking 3.5 ± 1.0 3.6 ± 1.2 0.22 .643
OIk: Emotional inhibition 2.5 ± 0.8 3.2 ± 1.1 8.35 .005**
OIk: Unrelenting standards 4.0 ± 1.0 4.2 ± 0.9 0.84 .364
OIk: Negativity 3.1 ± 1.4 3.5 ± 1.0 2.23 .141
OIk: Punitiveness 3.3 ± 1.2 3.6 ± 1.0 0.93 .337
YSQe-total score 3.0 ± 0.7 3.3 ± 0.8 2.94 .091
Schema modes (SMIrf)
CMl: Vulnerable child 2.7 ± 0.9 3.4 ± 1.1 8.63 .005**
CMl: Angry child 2.6 ± 0.7 3.0 ± 0.9 3.08 .084
CMl: Enraged child 1.4 ± 0.5 1.4 ± 0.5 0.09 .765
CMl: Impulsive child 2.2 ± 0.6 2.3 ± 0.8 0.66 .420
CMl: Undisciplined child 2.6 ± 0.6 2.7 ± 0.6 1.25 .268
CMl: Happy child 3.4 ± 0.9 2.9 ± 0.8 5.05 .028*
DCMm: Avoidant protector 3.4 ± 0.8 3.4 ± 0.8 0.08 .775
DCMm: Detached protector 2.1 ± 0.7 2.6 ± 1.0 7.29 .009**
DCMm: Self-soother 3.0 ± 0.9 3.3 ± 1.0 1.61 .210
DCMm: Self-aggrandizer 2.4 ± 0.7 2.6 ± 0.7 0.80 .373
DCMm: Bully and attack 1.6 ± 0.5 1.9 ± 0.7 4.19 .045*
DCMm: Perf. overcompensator 3.6 ± 0.8 3.9 ± 0.7 1.61 .209
DCMm: Susp. overcontroller 2.6 ± 0.7 2.9 ± 0.8 3.26 .075
DPMn: Punishing parent 2.2 ± 1.0 2.5 ± 0.9 1.27 .263
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Table 2 Comparison of psychopathology scores, early maladaptive schemas and schema modes between responders
and non-responders (Continued)
DPMn: Demanding parent 4.1 ± 0.9 4.1 ± 0.9 0.01 .940
Healthy adult 3.7 ± 0.9 3.7 ± 0.7 0.12 .730
SMIrf-total score 2.6 ± 0.4 2.9 ± 0.5 6.06 .016*
Note: aY-BOCS: Yale-Brown Obsessive-Compulsive Scale, bOCI-r: Obsessive Compulsive Inventory-revised, cBDI: Beck Depression Inventory, dCTQ: Childhood Trauma
Questionnaire, eYSQ: Young Schema Questionnaire, fSMIr: Schema Mode Inventroy-revised, gD: 1. Domain Disconnection, hIA: 2. Domain Impaired Autonomy, IIL: 3.
Domain Impaired Limits, jOD: 4. Domain Other-Directedness, kOI: 5. Domain Overvigilance & Inhibition, lCM: Child Mode, mDCM: Dysfunctional Coping Modes,
nDPM: Dysfunctional Parent Mode, *p < .05, **p < .01, ***p < .001.
Thiel et al. BMC Psychiatry  (2014) 14:362 Page 8 of 13of the EMS. In OCD treatment, results regarding treat-
ment expectations are inconsistent and refer to a limited
number of studies with small sample sizes [74,80-82]. Our
results support the assumption that negative expectations
about failure affect treatment success adversely. In ad-
dition, previous research has shown that failure was one
of the five EMS explaining most of the variance in anxiety
symptoms, and cognitive avoidance was predicted by fail-
ure in people suffering from posttraumatic stress [83,84].
Furthermore, failure predicted depressive symptoms and
anxiety in nonclinical samples and was associated with
depression severity [85,86].
Individuals scoring high on the so-called emotional
inhibition schema typically inhibit the expression of
feelings to avoid disapproval by others or shame, seem
very controlled and aim for perfect self-regulation [23].
Typically, anger, aggression, joy, sexual excitement andTable 3 Statistics of the regression analyses with post-treatm
F
1. Regression analysis Model 1 Failure 17.3


















Note: aY-BOCS: Yale-Brown Obsessive-Compulsive Scale, bBDI: Beck Depression Inve
Axis I disorders, *p < .05, **p < .01, ***p < .001.play are inhibited. In ERP treatment feared stimuli are
confronted, the experience of anxiety is desired and the
therapist supports emotional processes [63]. The inhib-
ition of feelings is often considered as an indication of
incorrect treatment or a lack of involvement of the pa-
tient. In line with these principles of ERP, our results
indicate that the suppression of emotions adversely af-
fects the treatment outcome and supports the concept
of experiential avoidance. Therapists should be aware, if
this EMS is prevalent in the patient, to counteract treat-
ment failures and should take time to build up a strong
therapeutic relationship to encourage inhibited patients
to reveal emotions and guide them in emotion regula-
tion without the use of maladaptive coping strategies.
Also in the present study, non-responders scored sig-
nificantly higher on this EMS prior to treatment than
responders. Furthermore, the emotional inhibition EMSent Y-BOCSa regressed by multiple variables (N = 67)
R2 R2 corr. B SE B β T
1 0.22 0.21*** 2.42 0.58 0.47 4.16***


















ntory, cCTQ: Childhood Trauma Questionnaire, dNo.CD: Number of comorbid
Thiel et al. BMC Psychiatry  (2014) 14:362 Page 9 of 13was previously declared as one of the key EMS in
obsessive-compulsive, anxiety and avoidant personality
disorders, explained a great part of the variance of anxiety
symptoms, correlated significantly with PTSD symptoms
and was identified as a negative predictor in bipolar dis-
order [32,84,87-92]. In addition, this EMS appeared to be
more resistant to short-term SSRI treatment than other
EMS in a sample of major depressive patients [104].
Our results regarding the EMS as predictors for treat-
ment outcomes in OCD are not in line with previous
results identifying the abandonment and self-sacrifice
schemas as outcome predictors [34]. This may be be-
cause these authors only considered two covariates in
their analyses. Moreover, the participants presented only
mild depressive symptoms and only a few fulfilled the
criteria for a depressive disorder. Furthermore, the re-
sults might also diverge due to cultural influences that
may exist between Norwegian and German samples.
It should be taken into consideration that the encoun-
tered results regarding the EMS may not only due to the
obsessive-compulsive psychopathology, but also to the
moderate depression severity of the patients since Atalay
et al. [101] demonstrated that depressive dispositions ac-
tivated EMS rather than anxious dispositions. Moreover,
it was proven that already short-term SSRI treatment re-
duced EMS activation levels for some EMS significantly
especially for patients suffering from severe depressive
symptoms [101].
Studies investigating schema modes in Axis I disorders
are very limited, with a total of only two studies
[33,53,63,64]. The present study revealed no relation be-
tween schema modes and treatment outcomes. Schema
modes reflect a current state rather than a trait and are
less stable than EMS [23]. An explanation for the miss-
ing relation to the treatment outcome could be that pa-
tients were not triggered by situations while answering
the questionnaires and thus the schema modes were in-
active. Depression severity emerged as the most promin-
ent predictive factor for treatment failure in the analyses
of the schema modes but not in the calculations con-
cerning the EMS. Even prior to treatment, non-
responders presented significantly higher depression
values than later responders. According to the literature,
the predictive value of depressive symptoms is inconclu-
sive with studies observing a relation to treatment failure
[65,67,69,95] while others did not [12,81,96,97,99]. How-
ever, severe depression and the presence of a Major De-
pressive Disorder (MDD) are continuously linked with
negative treatment outcomes [98,100]. In our study,
41.2% of the patients fulfilled the criteria for a MDD,
with the majority of patients (58.6%) suffering from
moderate MDD. This explains why some part of the pa-
tients received additional pharmacotherapy treatment.
Abramowitz [98] assumes that the negative impact ofdepression on treatment outcome could be explained by
the over-excitation some depressive patients present, as
this negatively affects the habituation process during ex-
posure therapy. Others assume that patients with OCD
and comorbid depression are not sufficiently motivated
for the challenging ERP treatment, suffer more severe
distress and functional impairment or have a greater dis-
position to misinterpret innocuous intrusive thoughts as
being significant [68,102]. Identifying depressive symp-
tom severity as a negative predictor for treatment out-
come is thus in line with one aspect of previous research
results. The number of comorbid axis I diagnoses was
not associated with treatment outcome in the present
study most likely because all axis I diagnoses were taken
into account. Our results indicate that depressive symp-
toms in OCD must receive greater attention and be
treated in more detail.
The limitations of this study include the use of merely
self-report measures to assess EMS and schema modes.
Self-report measures only allow the assessment of con-
scious aspects of EMS and schema modes. Furthermore,
those subjectively measured constructs are surveyed re-
trospectively. Further possible difficulties with this type
of measurement are strategic reporting, response styles
and the feeling of shame. Another limitation is the
relatively small sample size compared to the number of
predictors included in the analysis. Thus, the risk for
unstable linear regression models and the possibility
for type I errors are enhanced. A replication with larger
sample sizes is needed to demonstrate the robustness of
the identified EMS predictors. Moreover, no follow-up
data were gathered. In the future, the investigations of
long-term effects of EMS and schema modes on the
treatment outcome in OCD are desirable. Moreover,
previously identified outcome predictors in OCD treat-
ment, such as treatment motivation, patient adherence
and expectations, low insight and expressed emotions
were not included in the study because these variables
were not gathered. They may explain some of the vari-
ance of the present predictors failure, emotional inhi-
bition and depression [68]. Besides, the identification of
a predictor may lead to unwarranted hypotheses about
possible causalities. Lastly, no formal fidelity analyses
were conducted.
The strengths of the present study are that comorbidi-
ties, such as severe depressive or personality disorders,
were not excluded, as in most investigations. As a result,
it can be assumed that the examined OCD sample is
representative, which leads to the increased generali-
zability of the results. Furthermore, important variables
that were identified as predictors for treatment outcome
in previous studies, such as depression, axis I comorbid-
ity, traumatization, etc. were included in the current
statistical analysis to identify potential influences. In
Thiel et al. BMC Psychiatry  (2014) 14:362 Page 10 of 13addition, the results are based on a phase IV study con-
ducting the effective first-line treatment CBT with ERP
for OCD under real inpatient treatment conditions
treating seriously burdened patients.Conclusions
The present study successfully detected negative predic-
tors in OCD treatment. Based on the results, we suggest
the application of the EMS questionnaire and BDI-II
prior to treatment in OCD patients to identify the
degree of the EMS failure and emotional inhibition to-
gether with depression as potential negative influencing
treatment variables. Since non-responders additionally
showed a higher activation level in three EMS of the first
domain, emotional inhibition and different schema
modes compared to responders, the awareness about the
activation levels of EMS and schema modes may provide
an indication of patients responding well and poor to
treatment. If clinicians are aware of potential non-
responders at an early stage of treatment, an adjustment
of the treatment is possible to generate a more satisfac-
tory treatment outcome and to minimize subsequent
treatments. But there is good news for clinicians work-
ing with patients with a general higher EMS activation
level. Based on the data, we assume that these patients
will not be automatically non-responders.
As described above, CBT with ERP is successful in the
treatment of OCD. Changes in clinical symptoms and
most likely the underlying schemas are achieved, but
non-responders exist and relapses are known. Because
schema therapy (ST) was especially developed for pa-
tients not responding optimally to traditional CBT, and
because first studies yielded good results [23,103,104],
the use of schema therapeutic elements in the treatment
of OCD could help to specifically treat the identified
negative EMS predictors and subsequently further im-
prove the treatment outcome. Particularly in patients
presenting the EMS emotional inhibition, a schema
therapeutic approach might be beneficial, because it is
an emotion-focused method that prevents emotional
avoidance through the use of techniques named imagery
rescripting or chair work. Future research would benefit
from the examination of the application of the schema
therapeutic approach in CBT or the comparison of CBT
and ST in their efficacy in OCD treatment, especially in
non-responders. To date, only one study concerning axis
I disorders exists, which compares ST with traditional
CBT in veterans suffering from PTSD and demonstrates
ST to be more effective [87]. Lastly, further studies
should examine to what extent depressive symptom se-
verity is a mediator or moderator of EMS and schema
modes based on a mediator analysis with a predefined
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